-
Philip Morris International Discusses Its Marketing Practices
Philip Morris International Discusses Its Marketing Practices
Share
STAMFORD, Conn.--(BUSINESS WIRE)--Moira Gilchrist, Global Chief Communications Officer at Philip Morris International (PMI), clarifies company’s marketing practices and facts related to ZYN nicotine pouches.
Contacts
Philip Morris International
Travis Parman
Philip Morris International
T. +1 (475) 550-2737
E. travis.parman@pmi.com
Philip Morris International
More News From Philip Morris International
FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today’s action further enhances PMI’s leadership role in the smoke-free category. “We are del...
PMI U.S. Opens $1.2 Billion Aurora Campus, Strengthening U.S. Manufacturing and Export Capabilities
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc.’s (PMI) (NYSE: PM) U.S. businesses (PMI U.S.) today celebrated the opening of its Aurora, Colorado manufacturing campus, a landmark investment representing total capital expenditures of $1.2 billion from 2024-2028. The campus expands the company’s domestic manufacturing capabilities, strengthens supply chain resilience, and positions Aurora as a strategic production and export hub supporting future growth. The site began commercial...
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke,...
